CytomX Therapeutics, Inc. (CTMX): Weighted Average Diluted Shares
137.94M
Year ended 2025-12-31
+28.0%
3-year compound annual growth
+24.5%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 137.94M | +62.8% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | 84.75M | +14.8% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | 73.81M | +12.3% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | 65.74M | +2.5% | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | 64.15M | +39.0% | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | 46.15M | +1.8% | 2023-03-27, From 2020-01-01 |
| 2019-12-31 | 45.34M | n/a | 2023-03-27, From 2019-01-01 |